Who We  Are

INVITRO Holding Limited owns medical businesses in five countries: Russia, Ukraine, Belarus, Kazakhstan and Armenia.

The mission of the company is to create a new model of healthcare, a credible modern healthcare with “human face”, which is based on professional ethics, latest technological solutions and innovations.

Subsidiary structures

INVITRO – Russia

Includes 9 regional Agglomerations in Russia: agglomeration Moscow (General Manager – Mr. Alexander Ostrovskiy); agglomeration North-West (General Manager – Ms. Elena Cherner); agglomeration Siberia (General Manager – Mr. Alexander Khamidulin); agglomeration Ural (General Manager – Mr. Andrey Tarasov); agglomeration Volga (Privolzhye) (General Manager – Mr. Andrey Logvin); agglomeration Center (General Manager – Mr. Roman Gamov); agglomeration South (General Manager – Mr. Marat Abdullayev); agglomeration North Caucasus (General Manager – Mr. Borislav Ivlev); agglomeration Far East (General Manager – Mr. Alexander Khamidulin).

The largest private medical company in Russia founded in 1995.

The company provides individuals and legal entitles with laboratory, instrumental and radiological diagnostics services, provides doctors and patients lifelong healthcare. It is represented by clinical diagnostic laboratories as well as a network of medical offices and diagnostic centers.

It also provides pre-trip and post-trip inspections of vehicle drivers, water and soil analysis services, clinical trials for medical equipment, sanitary and epidemiological assessment of premises and other medical services.

The company develops business on a franchise model in different regions of presence.

Licenses for medical activities:

INVITRO – Ukraine

General Manager – Ruslan Golotov.

Medical company that provides individuals and legal entitles laboratory and instrumental diagnostic services. It is represented by a network of medical offices, a clinical diagnostic laboratory and an outpatient medical service.

INVITRO – Kazakhstan

General Manager – Fuat Diveev.

Medical company that provides individuals and legal entitles laboratory and instrumental diagnostic services. It is represented by a network of medical offices, a clinical diagnostic laboratory and an outpatient medical service.

INVITRO – Belarus

General Manager – Mr. Alexey Vydritskiy.

Medical company that provides individuals and legal entitles laboratory and instrumental diagnostic services. It is represented by a network of medical offices, a clinical diagnostic laboratory and an outpatient medical service.

INVITRO- Kyrgyzstan

General Manager – Ms. Svetlana Chekushkina

Medical company that provides individuals and legal entitles laboratory and instrumental diagnostic services. It is represented by a network of medical offices, a clinical diagnostic laboratory and an outpatient medical service.

0
Laboratory facilities
0
Medical Offices
0
Tests per year
0
Patients received by INVITRO every year

Principles of Our Work

1. Quality

INVITRO is committed to ensuring, maintaining, and perfecting its high quality and to expanding the range of its services in clinical laboratory diagnostics and other medical services it provides to its corporate and individual customers as well as expanding its geography in the laboratory diagnostics market by attracting consumers in Russia and abroad.  INVITRO participates in several external quality assessment systems:

  • FSVOK – Federal Service of External Assessment for Quality of Laboratory Tests (Russia);
  • RIQAS – Randox (United Kingdom);
  • EQAS – BIO-Rad (USA).

2. Trust

Ethical practices and principles in dealing with all stakeholder groups, the business community, and society in general are the fundamental business principles of INVITRO. The company’s high standards of business ethics reflect the ethical stand of its shareholders, and are mandatory for all employees, from support staff to top management. The heart of INVITRO’s relations with all of its partners is trust, which stems from the impeccable business reputation of the company and its management.

3. Innovations

Innovation is one of the core goals for INVITRO. The company’s professionals follow a great number of international scientific publications for information on the emergence, establishment, and maturity of new technologies in medicine and healthcare, molecular biology, digital and personalized medicine, and cellular technology, among others.

Our Gallery